GAFFX
Price
$78.34
Change
-$0.95 (-1.20%)
Updated
Jun 13 closing price
Net Assets
306.22B
MXLGX
Price
$10.53
Change
-$0.13 (-1.22%)
Updated
Jun 13 closing price
Net Assets
1.75B
Interact to see
Advertisement

GAFFX vs MXLGX

Header iconGAFFX vs MXLGX Comparison
Open Charts GAFFX vs MXLGXBanner chart's image
American Funds Growth Fund of Amer F3
Price$78.34
Change-$0.95 (-1.20%)
VolumeN/A
Net Assets306.22B
Empower Large Cap Growth I
Price$10.53
Change-$0.13 (-1.22%)
VolumeN/A
Net Assets1.75B
GAFFX vs MXLGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GAFFX vs. MXLGX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a Buy and MXLGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 306B vs. MXLGX (1.75B). GAFFX pays higher dividends than MXLGX: GAFFX (0.65) vs MXLGX (0.00). GAFFX was incepted earlier than MXLGX: GAFFX (8 years) vs MXLGX (22 years). MXLGX (0.99) is less costly to investors than GAFFX (0.30). MXLGX is a more actively managed with annual turnover of: 31.00 vs. GAFFX (25.00). MXLGX has a lower initial minimum investment than GAFFX: MXLGX (0) vs GAFFX (1000000). GAFFX annual gain was more profitable for investors over the last year : 7.65 vs. MXLGX (0.29). GAFFX return over 5 years is better than : 51.03 vs. MXLGX (7.25).
GAFFXMXLGXGAFFX / MXLGX
Total Expense Ratio0.300.9831%
Annual Report Gross Expense Ratio0.300.9930%
Fund Existence8 years22 years-
Gain YTD5.1972.035255%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets306B1.75B17,486%
Annual Yield % from dividends0.650.00-
Returns for 1 year7.650.292,679%
Returns for 3 years54.6145.33120%
Returns for 5 years51.037.25704%
Returns for 10 yearsN/A11.95-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEU648.70-6.24
-0.95%
NewMarket Corp
GILD109.98-1.28
-1.15%
Gilead Sciences
BVS6.62-0.09
-1.34%
Bioventus
KLRS2.64-0.12
-4.35%
Kalaris Therapeutics Inc
VSCO18.19-1.62
-8.18%
Victoria's Secret & Co